Drugs / Asasantin®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02273479 | Jul → Sep 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Asasantin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02273479 ↗ |
| Known as | RAD-SP | “Asasantin® extended release (RAD-SP)” NCT02273479 ↗ |